New wrinkles in lipoprotein lipase biology
暂无分享,去创建一个
Stephen G. Young | S. Young | A. Beigneux | Brandon S. J. Davies | L. Fong | Brandon S.J. Davies | Anne P. Beigneux | Loren G. Fong
[1] S. Young,et al. Highly Conserved Cysteines within the Ly6 Domain of GPIHBP1 Are Crucial for the Binding of Lipoprotein Lipase* , 2009, The Journal of Biological Chemistry.
[2] R. Eckel,et al. Spinal cord of the rat contains more lipoprotein lipase than other brain regions. , 1993, Journal of lipid research.
[3] J. O’Connell,et al. A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection , 2008, Science.
[4] S. Young,et al. The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma. , 2008, Molecular endocrinology.
[5] M. Hayden,et al. A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis. , 1998, Clinica chimica acta; international journal of clinical chemistry.
[6] J. Polonovski,et al. [Structure and metabolism of plasma lipoproteins]. , 1983, Pathologie-biologie.
[7] S. Young,et al. Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1 , 2011, Proceedings of the National Academy of Sciences.
[8] Oliver T. Bruns,et al. Brown adipose tissue activity controls triglyceride clearance , 2011, Nature Medicine.
[9] M. Hayden,et al. Presynaptic Defects Underlying Impaired Learning and Memory Function in Lipoprotein Lipase-Deficient Mice , 2009, The Journal of Neuroscience.
[10] Junhua Ge,et al. MicroRNA‐29a regulates pro‐inflammatory cytokine secretion and scavenger receptor expression by targeting LPL in oxLDL‐stimulated dendritic cells , 2011, FEBS letters.
[11] G. Olivecrona,et al. Childhood‐onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation , 2011, Journal of internal medicine.
[12] P. Kinnunen,et al. Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[13] Kenichi Yoshida,et al. ANGPTL3 Decreases Very Low Density Lipoprotein Triglyceride Clearance by Inhibition of Lipoprotein Lipase* , 2002, The Journal of Biological Chemistry.
[14] S. Young,et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. , 2007, Cell metabolism.
[15] S. Young,et al. Assessing the Role of the Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1) Three-finger Domain in Binding Lipoprotein Lipase* , 2011, The Journal of Biological Chemistry.
[16] T. Olivecrona,et al. Lipoprotein lipase. Mechanism of product inhibition. , 1980, European journal of biochemistry.
[17] S. Bertolini,et al. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. , 2006, Current opinion in lipidology.
[18] S. Young,et al. Chylomicronemia With Low Postheparin Lipoprotein Lipase Levels in the Setting of GPIHBP1 Defects , 2010, Circulation. Cardiovascular genetics.
[19] R. Eckel,et al. Lipoprotein lipase : from gene to obesity , 2009 .
[20] S. Deeb,et al. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. , 1992, Journal of lipid research.
[21] D. Rader,et al. Angiopoietin-like Protein 3 Inhibits Lipoprotein Lipase Activity through Enhancing Its Cleavage by Proprotein Convertases* , 2010, The Journal of Biological Chemistry.
[22] C. Proud,et al. Protein Kinase D Is a Key Regulator of Cardiomyocyte Lipoprotein Lipase Secretion After Diabetes , 2008, Circulation research.
[23] M. Nyegaard,et al. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking , 2011, Journal of Cell Science.
[24] D. Lougson,et al. Acute. , 2020, The Manchester medical gazette.
[25] T. Olivecrona,et al. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue , 2006, Proceedings of the National Academy of Sciences.
[26] E. Lefai,et al. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. , 2011, The Journal of clinical endocrinology and metabolism.
[27] A. Catapano. Apolipoprotein C-II and lipoprotein lipase activity , 1982, La Ricerca in clinica e in laboratorio.
[28] K. Holmstrøm,et al. Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy. , 2010, Human immunology.
[29] S. Young,et al. GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons , 2007, Current opinion in lipidology.
[30] S. Young,et al. The Acidic Domain of GPIHBP1 Is Important for the Binding of Lipoprotein Lipase and Chylomicrons* , 2008, Journal of Biological Chemistry.
[31] L. Pennacchio,et al. Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[32] Jonathan C. Cohen,et al. An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.
[33] P. Puthanveetil,et al. Acute Diabetes Moderates Trafficking of Cardiac Lipoprotein Lipase Through p38 Mitogen-Activated Protein Kinase–Dependent Actin Cytoskeleton Organization , 2008, Diabetes.
[34] F. Wang,et al. Severity of Diabetes Governs Vascular Lipoprotein Lipase by Affecting Enzyme Dimerization and Disassembly , 2011, Diabetes.
[35] P. Madsen,et al. The sortilin cytoplasmic tail conveys Golgi–endosome transport and binds the VHS domain of the GGA2 sorting protein , 2001, The EMBO journal.
[36] M. Hayden,et al. A new mutation destroying disulphide bridging in the C-terminal domain of lipoprotein lipase. , 1996, Biochemical and biophysical research communications.
[37] S. Young,et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. , 2010, Cell metabolism.
[38] S. Young,et al. Abnormal Patterns of Lipoprotein Lipase Release into the Plasma in GPIHBP1-deficient Mice* , 2008, Journal of Biological Chemistry.
[39] B. Rodrigues,et al. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[40] R. Norum,et al. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. , 1986, The Journal of clinical investigation.
[41] T. Olivecrona,et al. Localization of lipoprotein lipase to discrete areas of the guinea pig brain , 1990, Brain Research.
[42] R. Eckel,et al. Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. , 2011, Cell metabolism.
[43] C. Chang,et al. Synthesis and regulation of lipoprotein lipase in the hippocampus. , 1990, Journal of lipid research.
[44] R. Hegele,et al. The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism , 2011, Nature Medicine.
[45] M. Hayden,et al. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia , 2010, Journal of Lipid Research.
[46] R. Hegele,et al. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650) , 2007, Lipids in health and disease.
[47] C. Bunker,et al. Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. , 2002, Atherosclerosis.
[48] T. Kirchgessner,et al. Localization of lipoprotein lipase mRNA in selected rat tissues. , 1989, Journal of lipid research.
[49] A. Tanigami,et al. CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. , 2001, Nucleic acids research.
[50] W. Kohr,et al. Cloning and expression of human apolipoprotein D cDNA. , 1986, The Journal of biological chemistry.
[51] F. Toledo,et al. A role of apolipoprotein D in triglyceride metabolism[S] , 2010, Journal of Lipid Research.
[52] P. Alaupovic,et al. Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. , 1976, Biochemistry.
[53] Sanjoy Ghosh,et al. Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites. , 2003, Journal of molecular and cellular cardiology.
[54] C. Fraser,et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. , 2005, Endocrinology.
[55] R. Havel,et al. Significance of lipoprotein lipase in rat skeletal muscle. , 1977, Advances in experimental medicine and biology.
[56] T. Olivecrona,et al. The Ins and Outs of Adipose Tissue , 2009 .
[57] F. Wang,et al. Cleavage of Protein Kinase D After Acute Hypoinsulinemia Prevents Excessive Lipoprotein Lipase–Mediated Cardiac Triglyceride Accumulation , 2009, Diabetes.
[58] R. Havel,et al. The significance of lipoprotein lipase in rat skeletal muscles. , 1977, Journal of lipid research.
[59] S. Young,et al. Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[60] J. Nyengaard,et al. Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA , 2007, Molecular and Cellular Biology.